ArticleThe Journal of clinical investigation2021

RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.

Filip Matthijssens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.